by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles Among patients with non–muscle-invasive bladder cancer, neoadjuvant mitomycin demonstrated favorable safety. Read More
by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles I reflect on how a generic mammogram reminder overlooked my experience as a breast cancer survivor and how thoughtful messaging could make a difference. Read More
by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer. Read More
by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer. Read More
by MM360 Staff | Apr 28, 2025 | Uncategorized
Source: CureToday articles Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population. Read More
by MM360 Staff | Apr 27, 2025 | Uncategorized
Source: CureToday articles HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death. Read More
